What are your priorities for your clinical trial supply in 2013? Pharma IQ recently published the results of an industry-led clinical trials supply survey.
Download this report and discover how to:
- Reduce overage through implementing product pooling and just in time labelling with strategies from our expert advisory panel
- Leverage outsourcing opportunities by learning best practice in distribution and logistics
- Get to grips with GDP regulations to understand the latest requirements for controlled room temperature
4 Key findings from the report include:
- Supporting numerous clinical trials is the main priority for respondents for the next 5 years
- 42% run between 1 and 10 active trials annually
- 71% predict the number of trials in BRIC countries to increase in the next 12 month
- China was selected as the most likely popular destination for clinical trials in the next 5 years at 35.4%
This survey report was created as a part of the pre-conference research for the 3rd Annual Clinical Supply Europe, Congress Centre Basel, Switzerland - 30th January - 1st February
Download PDF Attachment